UNC Lineberger Comprehensive Cancer Center: Leukemia, Myeloid, Acute trials

The registry lists 10 Leukemia, Myeloid, Acute studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 3 are open to participants now and 2 have results posted.

Phase 1 3Phase 2 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AMLNot yet recruitingNCT07605949Phase 2
• Registry of Older Patients With CancerRecruitingNCT01137825
• Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruitingNCT01137643
• RN-Led Palliative and Supportive Care InterventionCompletedNCT04570709Not applicableResults posted
• High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AMLCompletedNCT02768792Phase 2Results posted
• Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)TerminatedNCT04920188
• Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML PatientsCompletedNCT03488862
• Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard InductionCompletedNCT01578954Phase 1
• PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasCompletedNCT01169012Phase 1
• Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT00577694Phase 1